Cxcr2, a chemokine receptor on cellular surface, could upregulate and activate microglia in cerebral stoke, Alzheimer’s disease and multiple sclerosis [57–59, 60]. Here, CXCR2 is linked to early-onset autosomal dominant Alzheimer disease.